Focus on... ramelteon: a novel melatonin receptor agonist for the treatment of insomnia.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2005 AND VI 40 AND IP 5
Results: 26
1
2
Hepatitis.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 168
- Publication type:
- Article
3
Selected websites.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 168
- Publication type:
- Article
4
Thymalfasin.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 168
- Publication type:
- Article
5
Telbivudine.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 168
- Publication type:
- Article
6
Peginterferon alfa-2a.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 168
- Publication type:
- Article
7
Interferon affacon-1.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 168
- Publication type:
- Article
8
California HMOs required to cover all 'medically necessary' drugs.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 167
- Publication type:
- Article
9
New board to improve internal oversight, consumer communication of drug safety issues.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 167
- Publication type:
- Article
10
Safety.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 166
- Publication type:
- Article
11
Type 2 diabetes therapies may increase HF risk.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 166
- Publication type:
- Article
12
Clopidogrel beneficial during acute phase of Ml; metoprolol has no overall effect.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 162
- Publication type:
- Article
13
Drug-eluting stent comparisons give slight edge to sirolimus-eluting stent.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 159
- Publication type:
- Article
14
Calcium antagonist has clinical advantage over beta-blocker as initial antihypertensive therapy.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 158
- Publication type:
- Article
15
Evidence supports high-dose over low-dose atorvastatin in stable coronary heart disease.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 158
- Publication type:
- Article
16
Secondary stroke prophylaxis: ARB bests calcium antagonist.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 157
- Publication type:
- Article
17
Warfarin underperforms in preventing stroke in the real world in patients with chronic AF.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 156
- Publication type:
- Article
18
From the International Stroke Conference and the American College of Cardiology Scientific Session.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 156
- By:
- Publication type:
- Article
19
Ramelteon.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 146
- By:
- Publication type:
- Article
20
First-time generic approvals.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 145
- Publication type:
- Article
21
Hyzaar.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 145
- Publication type:
- Article
22
Boniva.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 144
- Publication type:
- Article
23
Xibrom.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 144
- Publication type:
- Article
24
Pipeline preview.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 144
- Publication type:
- Article
25
FDA actions in brief.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 142
- Publication type:
- Article
26
Baraclude.
- Published in:
- Formulary, 2005, v. 40, n. 5, p. 142
- Publication type:
- Article